Metoclopramide - Isotope Labelled Standards
References
FAQ's
References
- Arita, Takaichi; Hori, Ryohei; Ito, Keiji; Ichikawa, Kazuo, Transformation and excretion of drugs in biological systems. III. Separatory determination of metoclopramide and its N4-glucuronide and N4-sulfonate in rabbit urine and bile, Chemical & Pharmaceutical Bulletin, Volume: 18, Issue: 8, Pages: 1670-4, 1970 DOI: (1248/cpb.18.1670)
- Teng, Lina; Bruce, Robert B.; Dunning, L. Kay, Metoclopramide metabolism and determination by high-pressure liquid chromatography, Journal of Pharmaceutical Sciences, Volume: 66, Issue: 11, Pages: 1615-18, 1977 DOI: (1002/jps.2600661128)
Frequently Asked Questions
Which analytical method determines the oxidation and photolytic degradation of Metoclopramide?
The LC-MS method determines the oxidation and photolytic degradation of Metoclopramide.
What is the analytical method to separate Metoclopramide from its impurities?
The reversed phase ultra-performance liquid chromatographic (RP-UPLC) method helps separate Metoclopramide from its impurities.
Why is it necessary to remove Metoclopramide impurities from the drug?
Metoclopramide impurities can affect drug safety and quality and pose health risks, so it is necessary to remove them from the drug.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.